The specific anatomy of the liver with it’s dual vascular supply affords a unique opportunity to explore intra-arterial therapies for hepatic malignancies. Chemoembolization combines intra-arterial chemotherapy with delivery of embolic agents in order to achieve an antitumor effect due to a high local concentration and prolonged dwell time of the drug, along with select ischemia. Chemoembolization can produce significant results in terms of tumor shrinkage in patients with hepatocellular carcinoma, colorectal cancer, and neuroendocrine tumors.
Great presentation